RecruitingNCT07536841

Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis

Validation of the Odesa Criteria 2026 (OC26) for the Diagnosis of Autoimmune Pancreatitis

Sponsor

Military Medical Clinical Center of the Southern Region, Ukraine

Enrollment

82 participants

Start Date

May 1, 2026

Study Type

OBSERVATIONAL

Conditions

Pancreatic Cancer Chronic Pancreatitis IgG4-Related Diseases Autoimmune Pancreatitis

Summary

This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No intervention (observational study) for people with autoimmune pancreatitis, chronic pancreatitis, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.